| AD | Alzheimer’s disease |
| APP | amyloid precursor protein |
| Aβ | amyloid-β |
| CNS | central nervous system |
| ROS | reactive oxygen species |
| IL-1Ra | interleukin-1 receptor antagonist |
| IL-10 | interleukin-10 |
| TGF-β | transforming growth factor beta |
| TNF-α | tumor necrosis factor α |
| RNS | reactive nitrogen species |
| DAM | disease-associated microglia |
| IL-1β | interleukin-1β |
| IL-6 | interleukin-6 |
| iNOS | inducible nitric oxide synthase |
| ARG1 | arginase 1 |
| YM1 | chitinase-3-like protein 3 |
| COX2 | cyclooxygenase-2 |
| CD163 | cluster of differentiation 163 |
| NFT | neurofibrillary tangle |
| MGnD | microglial neurodegenerative phenotype |
| ARM | activated response microglia |
| MHC-II | major histocompatibility complex class II |
| DM | dark microglia |
| TEM | transmission electron microscopy |
| IRM | Interferon-response microglia |
| TLR | Toll-like receptors |
| IDE | insulin-degrading enzyme |
| NEP | neprilysin |
| RAGE | receptor for advanced glycation end products |
| NLRP3 | NOD-, LRR- and pyrin domain-containing protein 3 |
| IL-18 | interleukin-18 |
| IL-3 | interleukin-3 |
| IL-3Rα | interleukin 3 receptor alpha |
| GSK-3β | glycogen synthase kinase-3 beta |
| CSF1R | colony stimulating factor 1 receptor |
| NSAIDs | nonsteroidal anti-inflammatory drugs |
| CSF | cerebrospinal fluid |
| BACE1 | beta-site amyloid precursor protein cleaving enzyme 1 |
| BBB | blood–brain barrier |
| MMPs | matrix metalloproteinase |
| PPARs | Peroxisome proliferator-activated receptors |
| GFAP | glial fibrillary acidic protein |
| IL-4 | interleukin-4 |
| MAPK | mitogen-activated protein kinase |
| APOE | Apolipoprotein E |
| MSCs | mesenchymal stem cells |
| BM-MSCs | bone marrow mesenchymal stem cells |
| AD-MSCs | adipose tissue mesenchymal stem cells |
| UCB-MSCs | umbilical cord blood mesenchymal stem cells |
| WJ-MSCs | umbilical cord Wharton’s jelly mesenchymal stem cells |
| P-MSCs | placenta mesenchymal stem cells |
| iMGs | microglia-like cells |
| hiPSCs | human induced pluripotent stem cells |
| eCBs | endogenous cannabinoids/endocannabinoids |
| ECS | endocannabinoid system |
| CB1 | cannabinoid receptor 1 |
| CB2 | cannabinoid receptor 2 |
| THC | Δ9-tetrahydrocannabinol |
| CBD | cannabidiol |
| AEA | anandamide |
| 2-AG | 2-arachidonoylglycerol |
| TREM2 | triggering receptor expressed on myeloid cells 2 |
| NF-κB | nuclear factor kappa B |
| ASC | apoptosis-associated speck-like protein containing a CARD |
| C1q | complement component 1q |
| C3 | complement component 3 |
| C3aR | complement component 3a receptor |
| DAP12 | DNAX-activating protein of 12 kDa |
| TYROBP | transmembrane immune signaling adaptor TYROBP |
| SYK | spleen tyrosine kinase |
| GLP-1 | glucagon-like peptide-1 |
| ASO | antisense oligonucleotide |
| CD36 | cluster of differentiation 36 |
| CD14 | cluster of differentiation 14 |
| CD47 | cluster of differentiation 47 |
| ERK1/2 | extracellular signal-regulated kinases 1 and 2 |
| JNK | c-Jun N-terminal kinase |
| PGE2 | prostaglandin E2 |
| FAAH | fatty acid amide hydrolase |
| MAGL | monoacylglycerol lipase |
| DGAT1/2 | diacylglycerol O-acyltransferases 1 and 2 |
| ABCA1 | ATP-binding cassette transporter A1 |
| IL-1α | interleukin-1 alpha |
| ARIA | amyloid-related imaging abnormalities |
| RXR | retinoid X receptor |